Related Experiment Video
Updated: Jul 19, 2025

15:27
Internalization and Observation of Fluorescent Biomolecules in Living Microorganisms via Electroporation
Published on: February 8, 2015
17.0K
Characterization of Cellular Viability Using Label-Free Brightfield Live-Cell Imaging
Lewis Elson1,2, Amelie Tjaden1,2, Stefan Knapp1,2
1Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany.
Methods in Molecular Biology (Clifton, N.J.)
|August 9, 2023
Summary
This study presents a protocol for assessing compound effects on cell viability using live-cell imaging. It helps distinguish true drug effects from cytotoxicity in chemogenomic libraries.
Area of Science:
- Drug discovery and development
- Cell biology
- Chemical biology
Background:
- Chemogenomic libraries are crucial for phenotypic screening.
- Annotating compound effects on cellular viability is essential to differentiate on-target activity from cytotoxicity.
- Accurate compound quality control requires robust viability assays.
Purpose of the Study:
- To provide a standardized protocol for determining compound effects on cellular viability.
- To establish a method for initial compound quality control in phenotypic screening.
- To differentiate cytotoxic effects from specific on-target compound activity.
Main Methods:
- Utilizing the Incucyte live-cell imaging system for real-time monitoring.
- Calculating compound-induced changes in cellular growth rates.
- Classifying compound effects as cytotoxic, cytostatic, or healthy outcomes.
Main Results:
- The protocol effectively quantifies compound effects on cell viability.
- Compounds are reliably categorized based on their impact on cellular growth rates.
- This method serves as a primary screen for compound quality assessment.
Conclusions:
- The presented protocol is a valuable tool for initial compound quality control in chemogenomic library screening.
- Assessing cellular viability is a critical first step to ensure the reliability of phenotypic screening data.
- This approach aids researchers in prioritizing compounds with specific biological activity over those causing general toxicity.

